Page last updated: 2024-12-11

metopon

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID5359353
CHEMBL ID2110992
CHEBI ID135267
SCHEMBL ID25754
MeSH IDM0135610

Synonyms (32)

Synonym
metopon
metoponum [inn-latin]
methyldihydromorphinone
morphinan-6-one, 4,5-alpha-epoxy-3-hydroxy-5-beta-17-dimethyl-
brn 0044174
metopon [inn:ban]
metopone [dcit]
6-methyldihydromorphinone
morphinone, methyldihydro-
dea no. 9260
4,5-alpha-epoxy-3-hydroxy-5,17-diethylmorphinan-6-one
morphinone, dihydro-6-methyl-
dihydro-6-methylmorphinone
CHEBI:135267
metoponum
94xz1cc69d ,
unii-94xz1cc69d
143-52-2
metopone
SCHEMBL25754
metopon [who-dd]
morphinan-6-one, 4,5-epoxy-3-hydroxy-5,17-dimethyl-, (5.alpha.)-
ids-nm-006
(5.alpha.)-4,5-epoxy-3-hydroxy-5,17-dimethylmorphinan-6-one
metopon [mi]
metopon [inn]
5-methyldihydromorphinone
CHEMBL2110992
DTXSID20162275
Q2667888
(1s,5r,13r,17r)-10-hydroxy-4,13-dimethyl-12-oxa-4-azapentacyclo[9.6.1.0?,??.0?,??.0?,??]octadeca-7,9,11(18)-trien-14-one
(4r,4ar,7ar,12bs)-9-hydroxy-3,7a-dimethyl-2,4,4a,5,6,13-hexahydro-1h-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
morphinane alkaloidAn isoquinoline alkaloid based on a morphinan skeleton and its substituted derivatives.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (22)

TimeframeStudies, This Drug (%)All Drugs %
pre-199020 (90.91)18.7374
1990's1 (4.55)18.2507
2000's0 (0.00)29.6817
2010's1 (4.55)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 39.28

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index39.28 (24.57)
Research Supply Index3.18 (2.92)
Research Growth Index4.11 (4.65)
Search Engine Demand Index53.31 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (39.28)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (4.55%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other21 (95.45%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]